Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrp Advisory Group Regulatory News (FRP)

Share Price Information for Frp Advisory Group (FRP)

Share Price is delayed by 15 minutes
Get Live Data
117.00    4.00 (3.54%)
Bid:
116.00
Ask:
118.00
Spread: 2.00 (1.724%)
Market Cap: £289.10m
FRP Live PriceLast checked at - London Stock Exchange

Intraday Frp Advisory Group Share Chart

Total Voting Rights

30 Sep 2024 10:22

RNS Number : 2364G
FRP Advisory Group PLC
30 September 2024
 

30 September 2024

 

FRP Advisory Group plc

("FRP", the "Group" or the "Company")

Total Voting Rights

FRP Advisory Group plc, a leading national specialist business advisory firm, announces that the Company has 255,014,886 ordinary shares in issue with each ordinary share carrying the right to one vote and no ordinary shares held in treasury. The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Enquiries:

 

FRP Advisory Group plc

Geoff Rowley, CEO

Jeremy French, COO

Gavin Jones, CFO

Enquiries via MHP

 

Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker)

Katy Birkin/Stephen Keys/George Lawson (Corporate Finance)

Tel: +44 (0) 207 220 0500

 

Investec Bank plc (Joint Broker)

Carlton Nelson / James Rudd (Corporate Broking)

Tel: +44 (0) 207 597 4000

 

MHP Communications (Financial Public Relations)

Oliver Hughes

Eleni Menikou

Catherine Chapman

Tel: +44 (0) 7711 191518

 

FRP@mhpgroup.com 

 

Notes to Editors

FRP is a leading national specialist business advisory firm established in 2010. It offers a range of advisory services to companies, lenders, investors and other stakeholders, as well as individuals. These services include:

 

· Restructuring advisory: corporate financial advisory, formal insolvency appointments, informal restructuring advisory, personal insolvency and general advice to all stakeholders.

· Corporate finance: mergers & acquisitions (M&A), strategic advisory and valuations, financial due diligence, capital raising, special situations M&A and partial exits.

· Debt advisory: raising and refinancing debt, debt amendments and extensions, restructuring debt, asset based lending and corporate and leveraged debt advisory.

· ​Forensic services: forensic investigations, compliance and risk advisory, dispute services and forensic technology.

· Financial advisory: transaction services including financial due diligence, lender services, financial modelling, valuations, pensions and company-side advisory services. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVREANNEDAFLEEA
Date   Source Headline
21st May 20264:39 pmRNSHolding(s) in Company
21st May 20264:22 pmRNSPurchase of Ordinary Shares by EBT
15th May 20267:00 amRNSFull Year Trading Update
27th Apr 20267:00 amRNSShareholder Lock-Ins
20th Mar 202610:43 amRNSHolding(s) in Company
17th Mar 20261:49 pmRNSHolding(s) in Company
27th Feb 20266:15 pmRNSHolding(s) in Company
27th Feb 20266:08 pmRNSHolding(s) in Company
23rd Feb 20267:00 amRNSQ3 Dividend Declaration
13th Jan 20262:51 pmRNSChange of Auditor
9th Jan 20263:40 pmRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSGrant of Options and Director Dealing
19th Dec 20257:00 amRNSGrant of Options and Director Dealing
18th Dec 20257:00 amRNSHalf-year Report
1st Dec 20256:08 pmRNSTotal Voting Rights
21st Nov 20257:00 amRNSTrading Statement
14th Nov 20257:00 amRNSAcquisition of Arc & Co Structured Finance Limited
23rd Sep 20253:43 pmRNSResult of AGM
23rd Sep 20257:00 amRNSAGM Statement and Q1 Dividend Declaration
3rd Sep 20257:00 amRNSDirector/PDMR Shareholding
26th Aug 20255:32 pmRNSNotice of Annual General Meeting
19th Aug 202510:04 amRNSAnnual Financial Report
19th Aug 20258:45 amRNSGrant of Options and Director Dealing
23rd Jul 20257:00 amRNSFull Year Results
30th May 20257:00 amRNSTotal Voting Rights
12th May 20257:00 amRNSAcquisition of One Advisory Group
8th May 20257:00 amRNSFull Year Trading Update
1st May 20253:35 pmRNSAIM Rule 17 Update
11th Mar 20251:55 pmRNSDirector/PDMR Shareholding
17th Feb 20257:00 amRNSQ3 Trading Update and Dividend Declaration
14th Jan 20257:00 amRNSAppointment of Joint Corporate Broker
10th Jan 20255:00 pmRNSDirector/PDMR Shareholding
17th Dec 20247:00 amRNSHalf-year Report
20th Nov 20247:00 amRNSHalf Year Trading Update
31st Oct 20247:00 amRNSTotal Voting Rights
25th Oct 20247:00 amRNSHolding(s) in Company
17th Oct 20247:00 amRNSAcquisition of Globalview Advisors Limited
15th Oct 20242:42 pmRNSPDMR Dealing
30th Sep 202410:22 amRNSTotal Voting Rights
26th Sep 202410:49 amRNSResult of AGM
26th Sep 20247:00 amRNSAGM Statement and Q1 Dividend Declaration
23rd Sep 20247:00 amRNSDirector/PDMR Shareholding
4th Sep 20247:00 amRNSAcquisition of WilliamsAli Corporate Finance
23rd Aug 20247:00 amRNSNotice of AGM
16th Aug 202411:39 amRNSAnnual Report & Accounts
1st Aug 20243:35 pmRNSDirector/PDMR Shareholding
31st Jul 202410:50 amRNSTotal Voting Rights
24th Jul 20242:40 pmRNSReplacement - Full Year Results
24th Jul 20247:00 amRNSFull Year Results
19th Jul 202411:43 amRNSAcquisition of Lexington Corporate Finance

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.